// App-Quantinova.ai

465 : CD44 as a potential therapeutic target and prognosis marker for glioblastoma

Researchers

Presenter

  • Fengfei Wang

Principal Investigators

  • Xin Shen

  • Jessica Pruszynski

  • Jason Huang

  • Batool Kirmani

  • Erxi Wu

  • Ekokobe Fonkem

Medical Centers

  • Baylor Scott and White Health Care, Belton, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Glioblastoma

  • Brain cancer

  • Solid malignancies

Biomarkers

  • p53

  • Cluster of Differentiation 44

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved